High-Grade Mixed Adenoneuroendocrine Carcinoma in the Cecum: A Case Report

Sang Ho Shin; Sae Hee Kim; Sung Hee Jung; Ji Woong Jang; Min Seok Kang; Sang Il Kim; Ji Hye Kim; Jun Ho Lee

doi:10.3393/ac.2017.33.1.39

Articles

Page Path: HOME > Ann Coloproctol > Volume 33(1); 2017 > Article

Case Report High-Grade Mixed Adenoneuroendocrine Carcinoma in the Cecum: A Case Report: Sang Ho Shin, Sae Hee Kim, Sung Hee Jung, Ji Woong Jang, Min Seok Kang, Sang Il Kim, Ji Hye Kim, Jun Ho Lee; Annals of Coloproctology 2017;33(1):39-42.
DOI: https://doi.org/10.3393/ac.2017.33.1.39
Published online: February 28, 2017

Department of Internal Medicine, Eulji University Hospital, Eulji University College of Medicine, Daejeon, Korea.

Correspondence to: Sae Hee Kim, M.D. Department of Internal Medicine, Eulji University Hospital, Eulji University College of Medicine, 95 Dunsanseo-ro, Seo-gu, Daejeon 35233, Korea. Tel: +82-42-611-3000, Fax: +82-42-611-3261, cozy129@eulji.ac.kr

• Received: May 16, 2016 • Accepted: December 19, 2016

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

6,675 Views
67 Download
13 Web of Science
9 Crossref
10 Scopus

Full Article

Download PDF

Abstract
INTRODUCTION
CASE REPORT
DISCUSSION
ARTICLE INFORMATION
REFERENCES

Abstract

Gastrointestinal neoplasms with an exocrine and a neuroendocrine component are rare. Such neoplasms are called “mixed adenoneuroendocrine carcinomas” (MANECs) according to the most recent World Health Organization classification of gastrointestinal tract neoplasms. MANECs have no specific findings that distinguish them from pure adenocarcinomas. In addition, the optimal management strategy of MANECs is largely unknown. We describe the case of a 32-year-old man with dizziness and abdominal bloating. A cecal mass was suspected based on an image study done at a local clinic. We evaluated the cecal mass by using colonoscopy, contrast enhanced computed tomography of the abdomen, positron emission tomography-computed tomography, and laboratory studies. The patient underwent a right hemicolectomy and adjuvant chemotherapy. The final histopathological diagnosis was a high-grade MANEC of the ascending colon, tumor stage T3N2M0.
Keywords: Mixed adenoneuroendocrine carcinomas; MANECs

INTRODUCTION

The presence of a neuroendocrine component in gastrointestinal adenomas/adenocarcinomas or an exocrine component in gastrointestinal neuroendocrine neoplasms is reportedly frequently observed in routine practice. However, mixed exocrine-neuroendocrine tumors are rarely found [1]. According to the recent World Health Organization (WHO) classification, neoplasms with an exocrine and a neuroendocrine component are called “mixed adenoneuroendocrine carcinomas” (MANECs) [2]. We report a rare case of a MANEC that arose in the ascending colon and was not distinguishable from an adenocarcinoma.

CASE REPORT

A 32-year-old male was referred from a local clinic to our gastrointestinal department with complaints of dizziness and abdominal bloating. Despite 2 months of conservative treatment for abdominal discomfort, his condition had worsened. Endoscopy and abdominal sonography performed in the local clinic showed no specific findings and a huge mass in the cecal area, respectively. The cecal mass was evaluated by using abdominal computed tomography (CT), colonoscopy, and laboratory studies on admission to our hospital. Initial laboratory data showed 5.2 g/dL of hemoglobin and elevated levels of carcinoembryonic antigen (6.96 ng/mL). Colonoscopy revealed a large fungating mass with a tendency to bleed easily, which interrupted the lumen of the ascending colon (Fig. 1). Contrast enhanced CT of the abdomen showed invagination of the terminal ileum into the ascending colon with an ileocecal mass of 3 cm in size (Fig. 2A), suggestive of ileocecal intussusception due to ileocecal cancer with multiple metastatic mesenteric lymph nodes (Fig. 2B). Because the histology report based on a biopsy sample was a moderately differentiated adenocarcinoma with no other metastatic lesion noted except for several mesenteric and aortocaval lymph nodes on positron emission tomography-CT (PET/CT), the patient underwent a right hemicolectomy on the 7th day of admission.

Gross inspection of the lesion revealed a polypoid and ulceroinfiltrative growth measuring 8.0 cm × 5.5 cm in the cecum (Fig. 3). The mesocolon was macroscopically intact. The tumor involvement was approximately 70% of the circumference. The tumor invasion depth was to the subserosa. The proximal and the distal resection margins of the specimen were tumor free. Eleven of 49 lymph nodes were metastatic. Sheets of monomorphic large cells with large rounded nuclei and abundant cytoplasm were found on histopathologic examination of the cecal mass. Furthermore, islands of tumor cells with glandular structures accounted for more than 30% of the tumor (Fig. 4). Immunohistochemical examination revealed synaptophysin (strongly positive) and reactivity in the neuroendocrine differentiation area (Fig. 5). The final histopathological diagnosis was a high-grade MANEC of the ascending colon, tumor stage T3N2M0.

The patient underwent adjuvant chemotherapy. Adjuvant chemotherapy with 5FU and oxaliplatin (FOLFOX) was planned for six months, and the patient has undergone eight rounds of chemotherapy. The follow-up abdominal CT after four rounds of chemotherapy showed no evidence of tumor recurrence.

DISCUSSION

A description of exocrine-neuroendocrine tumors of the gastrointestinal tract was first published in 1924 [1]. Early reports since then, include several tumors with various names, such as composite carcinoid, mucin-producing carcinoid, argentaffin cell adenocarcinoma, goblet-cell carcinoid, adenocarcinoid, and small-cell undifferentiated carcinoma [3]. After Lewin's suggested classification of the neoplasm into 3 different subtypes, i.e., collision, combined, and amphicrine tumors, in 1987, the term “mixed tumor” was widely adopted [4]. In accordance with the 2000 WHO classification of endocrine tumors, such neoplasms were defined as mixed exocrine-endocrine tumors when each component represented at least 30% of the tumor [5]. Such neoplasms are now called “mixed adenoneuroendocrine carcinomas” (MANECs) according to the most recent WHO classification of gastrointestinal tract neoplasms [2].

A few studies of and some case reports on the rarely found MANEC tumor have been published. According to a recent review of endocrine cell carcinomas of the colon and rectum, most endocrine cell carcinomas of the colon and rectum are MANECs. Although the limited numbers of studies prevent our drawing generalized conclusions, the prognosis for patients with these tumors is poorer than it is for patients with routine colorectal cancer [6]. Hence, in most cases, the diagnosis should be confirmed solely by using a histologic study. MANECs containing a well-differentiated neuroendocrine tumor component and an adenocarcinoma component should be treated as adenocarcinomas. MANECs containing a poorly differentiated neuroendocrine carcinoma (NEC) component should be treated as NECs [7]. Patients with MANEC lesions containing a higher ratio of the adenocarcinoma component may have a better prognosis than patients with a lower ratio. However, circumspection is required for the interpretation of these results because the ratios of the adenocarcinoma component were obtained from only a small part of the whole tumor in the pathological specimen section.

The optimal management strategy for patients with a MANEC is largely unknown due to the rarity of these neoplasms. Generally, the more aggressive component of the MANEC should be taken into account when considering treatment. Adjuvant chemotherapy for patients with a MANEC should also be considered because some reports have indicated that it is effective [8]. However, which chemotherapy regimen is most effective in managing patients with a MANEC is not yet clear due to the small number of reports. Thus, there is no one best chemotherapy regimen for patients with a MANEC.

In conclusion, we reported a rare case of a patient with a MANEC, with particular emphasis on physician awareness of the term and the spectrum of MANECs, optimal treatment, and a better understanding of tumor prognosis. Also, additional studies are required to define more conclusively the optimal management for patients with MANECs to achieve improved outcomes.

ARTICLE INFORMATION

CONFLICT OF INTEREST: No potential conflict of interest relevant to this article was reported.

REFERENCES

1. La Rosa S, Marando A, Sessa F, Capella C. Mixed adenoneuroendocrine carcinomas (MANECs) of the gastrointestinal tract: an update. Cancers (Basel) 2012;4:11–30. Article PubMed PMC
2. Rindi G, Arnold R, Bosman FT. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, et al., editors. WHO classification of tumors of the digestive system. Lyon: IARC Press; 2010. p. 13–14.
3. Klappenbach RS, Kurman RJ, Sinclair CF, James LP. Composite carcinoma-carcinoid tumors of the gastrointestinal tract. A morphologic, histochemical, and immunocytochemical study. Am J Clin Pathol 1985;84:137–143. Article PubMed PDF
4. Lewin K. Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas. Am J Surg Pathol 1987;11(Suppl 1): 71–86. Article PubMed
5. Solcia E, Klöppel G, Sobin LH. Histological typing of endocrine tumours (WHO International Histological Classification of Tumours). 2nd ed. Berlin: Springer; 2000.
6. Komatsubara T, Koinuma K, Miyakura Y, Horie H, Morimoto M, Ito H, et al. Endocrine cell carcinomas of the colon and rectum: a clinicopathological evaluation. Clin J Gastroenterol 2016;9:1–6. Article PubMed PDF
7. Hervieu V, Scoazec JY. Mixed endocrine tumors. Ann Pathol 2005;25:511–528. Article PubMed
8. Vanacker L, Smeets D, Hoorens A, Teugels E, Algaba R, Dehou MF, et al. Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment. Anticancer Res 2014;34:5517–5521. PubMed

Fig. 1

Colonoscopic finding showed a large fungating mass that interrupts the lumen of the ascending colon.

Fig. 2

Contrast-enhanced computed tomography showed invagination of the terminal ileum into the ascending colon with an approximately 3 cm mass (A; arrow) and irregularly shaped multiple mesenteric lymph nodes with central low density (B; arrow).

Fig. 3

Gross findings revealed a polypoid and ulceroinfiltrative mass measuring 8.0 cm × 5.5 cm in the cecum.

Fig. 4

(A) Hematoxylin and eosin stained sample at ×40 magnification demonstrated sheets of monomorphic large cells with large round nuclei and abundant cytoplasm (inside the yellow line) and islands of tumor cells with glandular structures (inside the blue line). Hematoxylin and eosin stained tissue at ×200 magnification was consistent with a poorly differentiated adenocarcinoma (B) and a neuroendocrine carcinoma (C).

Fig. 5

(A) The tumor cells revealed a positive and diffuse reaction. Immunohistochemical staining for synaptophysin (×200). (B) The tumor cell revealed a positive reaction in the neuroendocrine differentiation area. Immunohistochemical staining for chromogranin (×200).

Figure & Data

References

Citations

Citations to this article as recorded by

Mixed neuroendocrine-non-neuroendocrine neoplasm of the colon treated with laparoscopic resection and adjuvant chemotherapy: a case report
Yuya Tanaka, Masayuki Takagi, Toshihiro Nakayama, Shuhei Kawada, Reika Matsushita, Tsunehisa Matsushita, Takahiro Ozaki, Shimpei Takagi, Sota Komai, Yasuhiro Sumi
Clinical Journal of Gastroenterology.2025; 18(2): 314. CrossRef
Colonic Mixed Neuroendocrine Nonneuroendocrine Neoplasm: Two Case Reports with Brief Review of Literature
Sanjay Sharma, Manoj Sharma, Neha Sethi, Abha Mathur, Maneesh K Vijay, Shweta Bansal, Shikha Goyal, Ankur Puniya
Journal of Mahatma Gandhi University of Medical Sciences and Technology.2024; 9(1): 53. CrossRef
Mixed adenoneuroendocrine carcinoma of the caecum presenting as extensive ileocolonic intussusception
Alessandro Iacomino, Ugo Grossi, Stefano Doratiotto, Alberto Brun Peressut, Patrizia Pelizzo, Giacomo Zanus
ANZ Journal of Surgery.2021;[Epub] CrossRef
Mixed adenoneuroendocrine carcinoma (MANEC) of the lower gastrointestinal tract: A systematic review with Bayesian hierarchical survival analysis
Ugo Grossi, Alessandro Bonis, Emma V. Carrington, Enrico Mazzobel, Giulio Aniello Santoro, Laura Cattaneo, Giovanni Centonze, Gaetano Gallo, Andrea Kazemi Nava, Maurizio Romano, Gian Luca Di Tanna, Giacomo Zanus
European Journal of Surgical Oncology.2021; 47(11): 2893. CrossRef
Neoadjuvant and Adjuvant Chemotherapeutic Strategy of Colorectal Mixed Adeno-Neuroendocrine Carcinomas
Anita Michael, Debashis K Nath
Cureus.2021;[Epub] CrossRef
Oncologic outcome of mixed adenoneuroendocrine carcinoma (MANEC): A single center case series
Audrius Dulskas, Algirdas Pilvelis
European Journal of Surgical Oncology.2020; 46(1): 105. CrossRef
Mixed epithelial endocrine neoplasms of the colon and rectum – An evolution over time: A systematic review
Rani Kanthan, Suresh Tharmaradinam, Tehmina Asif, Shahid Ahmed, Selliah C Kanthan
World Journal of Gastroenterology.2020; 26(32): 5181. CrossRef
Colorectal neuroendocrine carcinoma: A case report and review of the literature
Tomoaki Yoshida, Kenya Kamimura, Kazunori Hosaka, Koji Doumori, Hiromitsu Oka, Akito Sato, Yasuo Fukuhara, Shoji Watanabe, Tomomi Sato, Akira Yoshikawa, Takashi Tomidokoro, Shuji Terai
World Journal of Clinical Cases.2019; 7(14): 1865. CrossRef
Management of MANEC of the colon and rectum: A comprehensive review of the literature
Anna Paspala, Nikolaos Machairas, Anastasia Prodromidou, Eleftherios Spartalis, Argyrios Ioannidis, Ioannis Kostakis, Dimetrios Papaconstantinou, Nikolaos Nikiteas
Molecular and Clinical Oncology.2018;[Epub] CrossRef

Cite this Article

Cite this Article: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

High-Grade Mixed Adenoneuroendocrine Carcinoma in the Cecum: A Case Report

Ann Coloproctol. 2017;33(1):39-42. Published online February 28, 2017

DOI: https://doi.org/10.3393/ac.2017.33.1.39

XML Download

Figure

Related articles

Peritoneal metastatic mixed adenoneuroendocrine carcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a case report

High-Grade Mixed Adenoneuroendocrine Carcinoma in the Cecum: A Case Report

Fig. 1 Colonoscopic finding showed a large fungating mass that interrupts the lumen of the ascending colon.

Fig. 2 Contrast-enhanced computed tomography showed invagination of the terminal ileum into the ascending colon with an approximately 3 cm mass (A; arrow) and irregularly shaped multiple mesenteric lymph nodes with central low density (B; arrow).

Fig. 3 Gross findings revealed a polypoid and ulceroinfiltrative mass measuring 8.0 cm × 5.5 cm in the cecum.

Fig. 4 (A) Hematoxylin and eosin stained sample at ×40 magnification demonstrated sheets of monomorphic large cells with large round nuclei and abundant cytoplasm (inside the yellow line) and islands of tumor cells with glandular structures (inside the blue line). Hematoxylin and eosin stained tissue at ×200 magnification was consistent with a poorly differentiated adenocarcinoma (B) and a neuroendocrine carcinoma (C).

Fig. 5 (A) The tumor cells revealed a positive and diffuse reaction. Immunohistochemical staining for synaptophysin (×200). (B) The tumor cell revealed a positive reaction in the neuroendocrine differentiation area. Immunohistochemical staining for chromogranin (×200).